Skip to content
value.today
Atossa Genetics Inc. logo

Atossa Genetics Inc.

Total raised
$7 M
1 round on record
Latest round
$7 M
Apr 2011
First round on record
Apr 2011
Today
Went public
See the company page

Atossa Genetics Inc. is listed today as Atossa Genetics: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Atossa Genetics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2013$1 MPrivate placement after listingUnder $2 million

Atossa Genetics Inc.: Private sale, Mar 2013

Investors in this round

1 investor had bought by the notice of Apr 11, 2013: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $30 M offered; $29 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$61,075
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kyle C. Guse · Executive Officer
  • Shu-Chih C. Chen · Executive Officer, Director
  • Steven C. Quay · Executive Officer, Director
  • Alexander C. Cross · Director
  • H. Lawrence Remmel · Director
  • John C. Barnhart · Director
  • Stephen C. Galli · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • DAWSON JAMES SECURITIES, INC. (CRD 130645) · Boca Raton, FloridaSold in IL

Signed by Kyle Guse, Chief financial officer, general counsel, and secretary. Source: SEC Form D, newest notice filed Apr 11, 2013. Read the notice at the SEC.

equitySEC
Apr 2011$7 MNo. 1$2 to $10 million

Atossa Genetics Inc.: Raise no. 1, Apr 2011

Investors in this round

156 investors had bought by the notice of Jun 24, 2011: 156 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
$12,500
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$854,215
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher C. Benjamin · Executive Officer
  • Shu-Chih C. Chen · Executive Officer, Director
  • Steven C. Quay · Executive Officer, Director
  • Alexander C. Cross · Director
  • John C. Barnhart · Director
  • Stephen C. Galli · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • DAWSON JAMES SECURITIES, INC. (CRD 130645) · Boca Raton, FloridaSold in AL, CA, CO, CT, FL, GA, IL, IN, MA, MD, MN, MT, NC, NJ, NY, OR, PA, TX, VA, WA, WI

Signed by Steven C. Quay, Chief executive officer. Source: SEC Form D and 1 amendment, newest notice filed Jun 24, 2011. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Atossa Genetics Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2013).

    SEC Form D · Apr 2013

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Apr 2013

That is all the official record says: Atossa Genetics Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Atossa Genetics Inc. are on record.

Investors#

No investor of Atossa Genetics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 156 investors.

Largest shareholders today

Institutions holding Atossa Genetics shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Atossa Genetics Inc.
NameRoleNamed in
Kyle C. GuseExecutive officerApr 2013
Shu-Chih C. ChenExecutive officerApr 2013
Steven C. QuayExecutive officerApr 2013
Christopher C. BenjaminExecutive officerJun 2011
Alexander C. CrossDirectorApr 2013
H. Lawrence RemmelDirectorApr 2013
John C. BarnhartDirectorApr 2013
Shu-Chih C. ChenDirectorApr 2013
Stephen C. GalliDirectorApr 2013
Steven C. QuayDirectorApr 2013

About

Company in Seattle, United States.

Went public since 2012. Its SEC number is that of a company listed on a stock exchange.